IP Library Granted Patent US 9,353,385
Granted Patent B2
US 9,353,385 · App. 13/987,493 · Granted May 31, 2016

Sclareol and labdenediol diphosphate synthase polypeptides, encoding nucleic acid molecules and uses thereof

Inventors: Grace Eunyoung Park (Lexington, KY); Bryan N. Julien (Lexington, KY); Richard Burlingame (Nicholasville, KY)
Assignee: Evolva, Inc.
C12P7/02C12N9/88C12P7/18C12P9/00C12Y402/03Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,353,385
App. No.
13/987,493
Granted
May 31, 2016
Kind
B2
Abstract

Provided are labdenediol diphosphate synthase polypeptides, sclareol synthase polypeptides, nucleic acid molecules encoding the labdenediol diphosphate synthase polypeptides and sclareol synthase polypeptides, and methods of using the labdenediol diphosphate synthase polypeptides, sclareol synthase polypeptides. Also provided are methods for producing labdenediol diphosphate, sclareol and (−)-ambroxide.

Claims (18)

1. A host cell, comprising a cDNA molecule encoding a labdenediol diphosphate synthase polypeptide;

wherein the cDNA molecule encoding the labdenediol diphosphate synthase is heterologous to the host cell and is operably linked to a heterologous promoter;

wherein the labdenediol diphosphate synthase polypeptide comprises a sequence of amino acid residues that has at least 85% sequence identity to any of SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14 and 54; and

wherein the labdenediol diphosphate synthase polypeptide catalyzes production of a terpene from an acyclic pyrophosphate terpene precursor in the host cell.

2. The host cell of claim 1 , wherein the cDNA molecule encoding the labdenediol diphosphate synthase polypeptide has a sequence set forth in any of SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13 and 53.

3. The host cell of claim 1 , wherein the acyclic pyrophosphate terpene precursor is geranylgeranyl diphosphate (GGPP) and the terpene product is labdenediol diphosphate.

4. The host cell of claim 3 , wherein the host cell comprises heterologous nucleic acid encoding a GGPP synthase that catalyzes production of the GGPP.

5. The host cell of claim 1 that is a yeast cell.

6. The host cell of claim 1 wherein the labdenediol diphosphate synthase polypeptide comprises one or more heterologous domains or portions thereof from one or more different terpene synthases, wherein the domain is identified as Helix A; Loop 1; Helix B; Loop 2; Helix C; Loop 3; Helix D; Loop 4; Helix E; Loop 5; Helix F1; Loop 7; Helix G; Loop 8; Helix H; Loop 9; Helix I; Loop 10; Helix J; Loop 11; Helix K; Loop 12; Helix L; Loop 13; Helix M; Loop 14; Helix N; Loop 15; Helix O; Loop 16; Helix P; Loop 17; Helix Q; Loop 18; Helix R; Loop 19; Helix S; Loop 20; Helix T; Loop 21; Helix U; Loop 22; Helix V; Loop 23; Helix W; Loop 24; Helix X; Loop 25; Helix Y; Loop 26; Helix Z1; Loop 28; Helix AA; Loop 29; Helix AB; Loop 30; Helix AC or Loop 31.

7. A vector, comprising a cDNA molecule encoding a labdenediol diphosphate synthase polypeptide;

wherein the cDNA molecule encoding the labdenediol diphosphate synthase is operably linked to a heterologous promoter;

wherein the labdenediol diphosphate synthase polypeptide comprises a sequence of amino acid residues that has at least 85% sequence identity to the labdenediol diphosphate synthase polypeptide set forth in any of SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14 or 54.

8. The vector of claim 7 , wherein the vector is a prokaryotic vector, a viral vector or a eukaryotic vector.

9. The vector of claim 7 , wherein the vector is a yeast vector.

10. A host cell, comprising the vector of claim 7 .

11. A method for producing a labdenediol diphosphate synthase polypeptide, comprising:

(a) culturing the host cell of claim 1 or claim 10 under conditions suitable for expression of the cDNA molecule encoding the labdenediol diphosphate synthase polypeptide; and

(b) optionally isolating the labdenediol diphosphate synthase polypeptide.

Assignments (5)
CHANGE OF NAME Recorded Sep 5, 2025
From: MINNESOTA SPECIALTY YEAST LLC
To: LALLEMAND BIO-INGREDIENTS USA LLC
Reel/Frame 072176/0205 →
MERGER AND CHANGE OF NAME Recorded May 15, 2024
From: EVOLVA, INC.; MINNESOTA SPECIALTY YEAST LLC
To: MINNESOTA SPECIALTY YEAST LLC
Reel/Frame 067415/0084 →
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Oct 17, 2016
From: EVOLVA, INC.
To: EVOLVA, INC.
Reel/Frame 040381/0312 →
MERGER AND CHANGE OF NAME Recorded Feb 18, 2016
From: ALLYLIX INC.; ALLYLIX INC.
To: EVOLVA, INC.
Reel/Frame 037769/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2013
From: PARK, GRACE EUNYOUNG; JULIEN, BRYAN N.; BURLINGAME, RICHARD
To: ALLYLIX, INC.
Reel/Frame 031717/0612 →
Continuity (3)
Provisional Application 61741959 · Jul 30, 2012
Related Publication 20140073020A1 · Mar 13, 2014
Related Publication 20140349352A9 · Nov 27, 2014